KLRK1 and neoplasm: The expression of NK cell receptors, such as the Fc gamma receptor CD16, the C-type lectin receptor CD94 and the activation markers CD69, NKp30, NKp46 and NKG2D, were measured to investigate their anti-tumor potential.